315 related articles for article (PubMed ID: 18552874)
1. Cellular basis of drug-induced torsades de pointes.
Roden DM
Br J Pharmacol; 2008 Aug; 154(7):1502-7. PubMed ID: 18552874
[TBL] [Abstract][Full Text] [Related]
2. [Drug induced QT prolongation].
Altmann D; Eggmann U; Ammann P
Wien Klin Wochenschr; 2008; 120(5-6):128-35. PubMed ID: 18365152
[TBL] [Abstract][Full Text] [Related]
3. Is gender a risk factor for adverse drug reactions? The example of drug-induced long QT syndrome.
Drici MD; Clément N
Drug Saf; 2001; 24(8):575-85. PubMed ID: 11480490
[TBL] [Abstract][Full Text] [Related]
4. Dofetilide-induced long QT and torsades de pointes.
Aktas MK; Shah AH; Akiyama T
Ann Noninvasive Electrocardiol; 2007 Jul; 12(3):197-202. PubMed ID: 17617063
[TBL] [Abstract][Full Text] [Related]
5. A new biomarker--index of cardiac electrophysiological balance (iCEB)--plays an important role in drug-induced cardiac arrhythmias: beyond QT-prolongation and Torsades de Pointes (TdPs).
Lu HR; Yan GX; Gallacher DJ
J Pharmacol Toxicol Methods; 2013; 68(2):250-259. PubMed ID: 23337247
[TBL] [Abstract][Full Text] [Related]
6. Understanding drug-induced torsades de pointes: a genetic stance.
Kannankeril PJ
Expert Opin Drug Saf; 2008 May; 7(3):231-9. PubMed ID: 18462182
[TBL] [Abstract][Full Text] [Related]
7. Female gender does not influence the magnitude of ibutilide-induced repolarization delay and incidence of torsades de pointes in an in vivo rabbit model of the acquired long QT syndrome.
Johansson M; Carlsson L
J Cardiovasc Pharmacol Ther; 2001 Jul; 6(3):247-54. PubMed ID: 11584331
[TBL] [Abstract][Full Text] [Related]
8. Predicting drug-induced QT prolongation and torsades de pointes.
Roden DM
J Physiol; 2016 May; 594(9):2459-68. PubMed ID: 26660066
[TBL] [Abstract][Full Text] [Related]
9. Antiarrhythmic properties of a rapid delayed-rectifier current activator in rabbit models of acquired long QT syndrome.
Diness TG; Yeh YH; Qi XY; Chartier D; Tsuji Y; Hansen RS; Olesen SP; Grunnet M; Nattel S
Cardiovasc Res; 2008 Jul; 79(1):61-9. PubMed ID: 18367457
[TBL] [Abstract][Full Text] [Related]
10. Drug-induced QT-interval prolongation and proarrhythmic risk in the treatment of atrial arrhythmias.
Shantsila E; Watson T; Lip GY
Europace; 2007 Sep; 9 Suppl 4():iv37-44. PubMed ID: 17766322
[TBL] [Abstract][Full Text] [Related]
11. The QT interval and torsade de pointes.
Moss AJ
Drug Saf; 1999; 21 Suppl 1():5-10; discussion 81-7. PubMed ID: 10597863
[TBL] [Abstract][Full Text] [Related]
12. Drug-induced long QT syndrome.
Kannankeril P; Roden DM; Darbar D
Pharmacol Rev; 2010 Dec; 62(4):760-81. PubMed ID: 21079043
[TBL] [Abstract][Full Text] [Related]
13. Drug-induced QT Interval Prolongation in the Intensive Care Unit.
Etchegoyen CV; Keller GA; Mrad S; Cheng S; Di Girolamo G
Curr Clin Pharmacol; 2017; 12(4):210-222. PubMed ID: 29473523
[TBL] [Abstract][Full Text] [Related]
14. Drug-Induced QT Prolongation and Torsades de Pointes: An All-Exclusive Relationship or Time for an Amicable Separation?
Hondeghem LM
Drug Saf; 2018 Jan; 41(1):11-17. PubMed ID: 28853038
[TBL] [Abstract][Full Text] [Related]
15. Electrophysiologic characterization of the antipsychotic drug sertindole in a rabbit heart model of torsade de pointes: low torsadogenic potential despite QT prolongation.
Eckardt L; Breithardt G; Haverkamp W
J Pharmacol Exp Ther; 2002 Jan; 300(1):64-71. PubMed ID: 11752098
[TBL] [Abstract][Full Text] [Related]
16. Drugs that cause Torsades de pointes and increase the risk of sudden cardiac death.
Wolbrette DL
Curr Cardiol Rep; 2004 Sep; 6(5):379-84. PubMed ID: 15306095
[TBL] [Abstract][Full Text] [Related]
17. Cardiovascular drugs inducing QT prolongation: facts and evidence.
Taira CA; Opezzo JA; Mayer MA; Höcht C
Curr Drug Saf; 2010 Jan; 5(1):65-72. PubMed ID: 20210721
[TBL] [Abstract][Full Text] [Related]
18. Early afterdepolarizationlike activity in patients with class IA induced long QT syndrome and torsades de pointes.
Kurita T; Ohe T; Shimizu W; Suyama K; Aihara N; Takaki H; Kamakura S; Shimomura K
Pacing Clin Electrophysiol; 1997 Mar; 20(3 Pt 1):695-705. PubMed ID: 9080496
[TBL] [Abstract][Full Text] [Related]
19. Ibutilide-induced long QT syndrome and torsade de pointes.
Gowda RM; Punukollu G; Khan IA; Patlola RR; Tejani FH; Cosme-Thormann BF; Vasavada BC; Sacchi TJ
Am J Ther; 2002; 9(6):527-9. PubMed ID: 12424513
[TBL] [Abstract][Full Text] [Related]
20. Relationships between preclinical cardiac electrophysiology, clinical QT interval prolongation and torsade de pointes for a broad range of drugs: evidence for a provisional safety margin in drug development.
Redfern WS; Carlsson L; Davis AS; Lynch WG; MacKenzie I; Palethorpe S; Siegl PK; Strang I; Sullivan AT; Wallis R; Camm AJ; Hammond TG
Cardiovasc Res; 2003 Apr; 58(1):32-45. PubMed ID: 12667944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
